| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Pazopanib | FIMM | pan-cancer | AAC | -0.41 | 0.08 |
| mRNA | Vandetanib | FIMM | pan-cancer | AAC | -0.39 | 0.09 |
| mRNA | lapatinib | UHNBreast | pan-cancer | AAC | -0.33 | 0.3 |
| mRNA | GDC-0449 | FIMM | pan-cancer | AAC | -0.29 | 0.2 |
| mRNA | Vorinostat | FIMM | pan-cancer | AAC | -0.29 | 0.2 |
| mRNA | VX-680 | CTRPv2 | pan-cancer | AAC | -0.27 | 0.03 |
| mRNA | lapatinib | FIMM | pan-cancer | AAC | -0.25 | 0.2 |
| mRNA | Sunitinib | FIMM | pan-cancer | AAC | -0.25 | 0.3 |
| mRNA | Vorinostat | gCSI | pan-cancer | AAC | -0.24 | 7e-05 |
| mRNA | GSK-J4 | CTRPv2 | pan-cancer | AAC | -0.24 | 0.04 |